Original Research

Published on 08 Mar 2024

Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries

in Drugs Outcomes Research and Policies

Szczepan Jakubowski
Pawel Kawalec
Przemyslaw Holko
Iwona Kowalska-Bobko
Maria Kamusheva
Guenka Petrova
Pero Draganić
Leos Fuksa
Agnes Männik
Fanni Ispán

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369178

2,093 views

Review

Published on 07 Mar 2024

Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Xueying Ding
Shujie Sun
Jinjin Zhang
Huifang Zhao
Fenglan Lun
Xuemin Liu
Yiwan Zhen
Jinping Dong
Jingliang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1285012

2,101 views

Original Research

Published on 07 Mar 2024

Validity and reliability of the Romanian version of the Hill-Bone compliance to high blood pressure therapy scale

in Drugs Outcomes Research and Policies

Răzvan-Nicolae Rusu
Radu Sebastian Gavril
Daniela Carmen Ababei
Ioana Macadan
Andrei Ciobîcă
Camelia Nicolae
Răducu Ionuț Popescu
Walther Bild
Veronica Bild

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1256848

1,058 views

Original Research

Published on 23 Feb 2024

Digging in real-word electronic database for assessing CDK 4/6 inhibitors adherence in breast cancer patients from Romania

in Drugs Outcomes Research and Policies

Adina Turcu-Stiolica
Ion Udristoiu
Mihaela-Simona Subtirelu
Victor Gheorman
Madalina Aldea
Elena Adriana Dumitrescu
Simona Ruxandra Volovat
Dragos Mircea Median
Cristian Virgil Lungulescu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1345482

1,681 views

Brief Research Report

Published on 23 Feb 2024

Prevalence of inappropriateness of elemene injection for hospitalized cancer patients: a multicenter retrospective study

in Drugs Outcomes Research and Policies

Mingzheng Cen
Guojun Jiang
Yuhua Zhao
Zhenwei Yu
Minxian Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1334701

619 views

Original Research

Published on 20 Feb 2024

The characteristics and operations of “online pharmacies” investigated in relation to medicines popularised during the coronavirus pandemic: a cross-sectional study

in Drugs Outcomes Research and Policies

Oria Jason Oriakhi
Hamzeh Almomani
Nilesh Patel
Parastou Donyai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1346604

3,889 views
1 citation

Original Research

Published on 16 Feb 2024

Evaluation of medication safety assessment tools for pharmacist-led medication reviews: the Eastern European pilot project

in Drugs Outcomes Research and Policies

Anita Tuula
Piotr Merks
Magdalena Waszyk-Nowaczyk
Mariola Drozd
Galina Petrova
Reka Viola
Veera Bobrova
Michael Scott
Marje Oona
Daisy Volmer

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1348400

2,253 views
2 citations

Original Research

Published on 14 Feb 2024

The impact of level of documentation on the accessibility and affordability of new drugs in Norway

in Drugs Outcomes Research and Policies

Gro Live Fagereng
Anne Marit Morvik
Sara Reinvik Ulimoen
Anne Marthe Ringerud
Iselin Dahlen Syversen
Erik Sagdahl

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1338541

1,856 views
1 citation

Original Research

Published on 14 Feb 2024

Real-world data for the availability of pediatric medicines in Chinese hospitals: a multi-center survey and analysis

in Drugs Outcomes Research and Policies

Wen-Yi Ruan
Hui-Ying Chen
He-Ping Cai
Xiao-Ling Wang
Zhi-Gang Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1283068

777 views

Review

Published on 13 Feb 2024

What influences consumers’ online medication purchase intentions and behavior? A scoping review

in Drugs Outcomes Research and Policies

Yam B. Limbu
Bruce A. Huhmann

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1356059

5,462 views
8 citations

Review

Published on 13 Feb 2024

Progress in the study of reproductive toxicity of platinum-based antitumor drugs and their means of prevention

in Drugs Outcomes Research and Policies

Zhan Jin
Liu Zhao-Xia
Peng Fan-Ke
Zhang Wen-Juan
Wei Min-Li
Zeng Han-Yi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1327502

1,490 views

Original Research

Published on 08 Feb 2024

Impacts of national volume-based drug procurement policy on the utilization and costs of antihypertensive drugs in a Chinese medicine hospital: an interrupted time series analysis of 5138 patients

in Drugs Outcomes Research and Policies

Lili Shang
Yan Cheng
Jifang Zhou
Yuqing Bao
Desong Kong
Ruijian Huang
Yanfei Chen
Hao Wang
Ning Gu
Aixia Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1302154

1,557 views

Review

Published on 08 Feb 2024

Effectiveness of perindopril/amlodipine fixed-dose combination in the treatment of hypertension: a systematic review

in Drugs Outcomes Research and Policies

Truong Van Dat
Vo Linh Tu
Le Nguyen Anh Thu
Nguyen Nhat Anh Quang
Van Binh
Nguyen Thi Quynh Nga
Duong Hoang Loc
Tran Thi Hong Nguyen
Dao Ngoc Hien Tam
Hong-Han Huynh

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1156655

5,723 views
2 citations

Perspective

Published on 07 Feb 2024

Enhancing the clinical research workforce: a collaborative approach with human resources

in Drugs Outcomes Research and Policies

Denise C. Snyder
Heather Gaudaur
Mark Marchant
Laura Viera
Andrea McCubbin
William Verble
Angela Mendell
Christine Gilliam

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1295155

1,883 views

Review

Published on 07 Feb 2024

Esketamine combined with sufentanil versus sufentanil in patient-controlled intravenous analgesia: a meta-analysis

in Drugs Outcomes Research and Policies

Manman Yao
Baoxia Fang
Jinguo Yang
Peng Chen
Fuchao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1247646

2,392 views
3 citations

Original Research

Published on 05 Feb 2024

Cost-effectiveness of tumor-treating fields plus standard therapy for advanced non-small cell lung cancer progressed after platinum-based therapy in the United States

in Drugs Outcomes Research and Policies

Wentao Tian
Jiaoyang Ning
Liu Chen
Yu Zeng
Yin Shi
Gang Xiao
Shuangshuang He
Guilong Tanzhu
Rongrong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1333128

2,389 views
1 citation

Navigation group

Articles

Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries

Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis

Validity and reliability of the Romanian version of the Hill-Bone compliance to high blood pressure therapy scale

Digging in real-word electronic database for assessing CDK 4/6 inhibitors adherence in breast cancer patients from Romania

Prevalence of inappropriateness of elemene injection for hospitalized cancer patients: a multicenter retrospective study

The characteristics and operations of “online pharmacies” investigated in relation to medicines popularised during the coronavirus pandemic: a cross-sectional study

Evaluation of medication safety assessment tools for pharmacist-led medication reviews: the Eastern European pilot project

The impact of level of documentation on the accessibility and affordability of new drugs in Norway

Real-world data for the availability of pediatric medicines in Chinese hospitals: a multi-center survey and analysis

What influences consumers’ online medication purchase intentions and behavior? A scoping review

Progress in the study of reproductive toxicity of platinum-based antitumor drugs and their means of prevention

Impacts of national volume-based drug procurement policy on the utilization and costs of antihypertensive drugs in a Chinese medicine hospital: an interrupted time series analysis of 5138 patients

Effectiveness of perindopril/amlodipine fixed-dose combination in the treatment of hypertension: a systematic review

Enhancing the clinical research workforce: a collaborative approach with human resources

Esketamine combined with sufentanil versus sufentanil in patient-controlled intravenous analgesia: a meta-analysis

Cost-effectiveness of tumor-treating fields plus standard therapy for advanced non-small cell lung cancer progressed after platinum-based therapy in the United States